U K
B U S I N E S S
P A R K
home page

The information below comes from the UK Activity Report.
Click here for further details

Cambridge Biotechnology Cambridge Biotechnology, the developer of obesity treatments with 29 staff, has been acquired by Biovitrum of Sweden for undisclosed terms. 23-Mar-2005 Cambridge Biotechnology has received £6m of venture capital to fund the development of new treatments for pain and obesity. 25-Jul-2002 The information above comes from the UK Activity Report Copyright UK Business Park 1995-2007